DOSE-2-WEIGHT SYRINGE
Live / Registered — Registered and renewed (as of 03 Mar 2026)
What this means for you
Registered since 15 Dec 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Dec 2025).
Record
- Serial number
- 86414662
- Registration number
- 4871749
- Mark type
- Stylized text
- Filed
- 03 Oct 2014
- Published for opposition
- 28 Jul 2015
- Registered
- 15 Dec 2015
- Next maintenance due
- 15 Dec 2025
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Antiemetics; [ Cardiovascular pharmaceuticals; ] Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; ] Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; [ Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; ] Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; [ Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; ] Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; [ Pharmaceutical preparations for the treatment of heart rhythm disorders; ] [ Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; [ Pharmaceutical preparations for wounds; ] [ Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes; ] Vitamin and mineral preparations for medical use
Owner
- Asepsis Medical Technologies, LLC, Bradenton, FL, US
- Asepsis Medical Technologies, LLC, Sarasota, FL, US
- Asepsis Medical Technologies, LLC, Sarasota, FL, US
Prosecution history
- 03 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Mar 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Dec 2025 — TEAS SECTION 8 & 9 RECEIVED
- 15 Dec 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Aug 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 31 Aug 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 30 Aug 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 29 Mar 2022 — OFFICE ACTION ISSUED POU1
- 15 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Mar 2022 — TEAS SECTION 8 RECEIVED
- 15 Dec 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Dec 2015 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED